Pazoo, Inc.
PZOOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$26882
P/E Ratio—
52W High$0.00001
52W Low$0.000001
Pazoo, Inc.（PZOO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PZOO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2017-12 | 2016-12 | 2015-12 | 2014-12 | 2013-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | -659.07% | 99.51% | 83.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $-4.39 | $-252.53 | $-1077.54 | $-191.98 |
| Wtd Avg Shares | 0.12B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Pazoo, Inc.
关于Pazoo, Inc.（PZOO）损益表
Pazoo, Inc.（PZOO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2017财年，PZOO实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.00B)（净利率—）。
常见问题
PZOO · 4 问Pazoo, Inc.（PZOO）2017财年营收为$0.00B，同比down100.0%。
PZOO revenuePZOO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09